Clinical Trials List
Protocol NumberSHJ002-CS202
Completed
2022-04-01 - 2023-12-31
Phase II
Terminated2
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
162 participants
-
Global
162 participants
